Stay up-to-date with the Cipla Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...

Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by ...

Stay up-to-date with the Cipla Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...

Cipla's oncology drug Abraxane will be launched from its Goa facility while respiratory drug Advair will be rolled out from ...

Cipla , one of India's largest drugmaker by sales, reported a bigger-than-expected third-quarter profit on Tuesday, helped by ...

KR Choksey recommended accumulate rating on Cipla with a target price of Rs 1598 in its research report dated January 31 2025 ...

This achievement has earned recognition from the Asia Book of Records for engaging the largest number of doctors in a COPD awareness campaign during COPD Awareness Month.

Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday, helped by ...

Cipla reported a 48.73% increase in consolidated net profit for Q3 2024. The growth was attributed to improved performance ...

Cipla is confident of surpassing its FY25 guidance, with supply challenges for Lanreotide expected to ease by Q1FY26. The ...

Mumbai: Cipla has announced the appointment of Achin Gupta, Chief Executive Officer – One India Business (SMP) as the Global ...

Motilal Oswal retains Neutral on Cipla; see limited upside due to delayed niche product approvals. Learn more about the ...